After the latest report of bodies in the bayou, City Hall needs to fill the information vacuum, identify solutions and show Houstonians that policymakers are taking action, writes the editorial board.
The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...
Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...
The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk’s Wegovy and ...
Medications once used to treat illness are increasingly being taken for prevention. Experts explain what’s behind the ...
The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...
Just in time for the holidays, on December 15, 2025, the U.S. Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued an untitled letter (the “Letter”) to Karuna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback